Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant Pain

NCT00529087 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Constipation

Interventions

DRUG: N-methylnaltrexone bromide (MOA-728)
OTHER: placebo

Sponsor

Bausch Health Americas, Inc.

Collaborators

[object Object]